185 related articles for article (PubMed ID: 33087142)
1. Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain.
Callan N; Hanes D; Bradley R
J Transl Med; 2020 Oct; 18(1):401. PubMed ID: 33087142
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study.
Möller I; Rodas G; Villalón JM; Rodas JA; Angulo F; Martínez N; Vergés J
J Transl Med; 2023 Jun; 21(1):423. PubMed ID: 37386594
[TBL] [Abstract][Full Text] [Related]
3. Enriched Marine Oil Supplement Increases Specific Plasma Specialized Pro-Resolving Mediators in Adults with Obesity.
Al-Shaer AE; Regan J; Buddenbaum N; Tharwani S; Drawdy C; Behee M; Sergin S; Fenton JI; Maddipati KR; Kane S; Butler E; Shaikh SR
J Nutr; 2022 Jul; 152(7):1783-1791. PubMed ID: 35349683
[TBL] [Abstract][Full Text] [Related]
4. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
[TBL] [Abstract][Full Text] [Related]
5. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
6. Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study.
Souza PR; Marques RM; Gomez EA; Colas RA; De Matteis R; Zak A; Patel M; Collier DJ; Dalli J
Circ Res; 2020 Jan; 126(1):75-90. PubMed ID: 31829100
[TBL] [Abstract][Full Text] [Related]
7. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
[TBL] [Abstract][Full Text] [Related]
8. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
[TBL] [Abstract][Full Text] [Related]
9. Specialised pro-resolving mediators of inflammation in inflammatory arthritis.
Barden AE; Moghaddami M; Mas E; Phillips M; Cleland LG; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():24-9. PubMed ID: 27033423
[TBL] [Abstract][Full Text] [Related]
10. The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus.
Barden A; Shinde S; Phillips M; Beilin L; Mas E; Hodgson JM; Puddey I; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2018 Jun; 133():29-34. PubMed ID: 29789130
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.
Mas E; Barden A; Burke V; Beilin LJ; Watts GF; Huang RC; Puddey IB; Irish AB; Mori TA
Clin Nutr; 2016 Apr; 35(2):331-336. PubMed ID: 25908532
[TBL] [Abstract][Full Text] [Related]
12. Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation.
Barden A; Mas E; Croft KD; Phillips M; Mori TA
J Lipid Res; 2014 Nov; 55(11):2401-7. PubMed ID: 25187667
[TBL] [Abstract][Full Text] [Related]
13. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease.
Schaller MS; Chen M; Colas RA; Sorrentino TA; Lazar AA; Grenon SM; Dalli J; Conte MS
J Am Heart Assoc; 2020 Aug; 9(15):e016113. PubMed ID: 32696697
[TBL] [Abstract][Full Text] [Related]
14. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.
Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA
Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868
[TBL] [Abstract][Full Text] [Related]
15. Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).
Ramirez JL; Gasper WJ; Khetani SA; Zahner GJ; Hills NK; Mitchell PT; Sansbury BE; Conte MS; Spite M; Grenon SM
J Surg Res; 2019 Jun; 238():164-174. PubMed ID: 30771686
[TBL] [Abstract][Full Text] [Related]
16. Disruption of pulmonary resolution mediators contribute to exacerbated silver nanoparticle-induced acute inflammation in a metabolic syndrome mouse model.
Alqahtani S; Xia L; Jannasch A; Ferreira C; Franco J; Shannahan JH
Toxicol Appl Pharmacol; 2021 Nov; 431():115730. PubMed ID: 34601004
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain.
Yoon DH; Bin SI; Chan SK; Chung CK; In Y; Kim H; Lichauco JJ; Mok CC; Moon YW; Ng TK; Penserga EG; Shin DA; You D; Moon H
BMC Musculoskelet Disord; 2017 Aug; 18(1):337. PubMed ID: 28778219
[TBL] [Abstract][Full Text] [Related]
18. Impact of omega-3 fatty acid oral therapy on healing of chronic venous leg ulcers in older adults: Study protocol for a randomized controlled single-center trial.
McDaniel JC; Rausch J; Tan A
Trials; 2020 Jan; 21(1):93. PubMed ID: 31948466
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements.
Schaller MS; Zahner GJ; Gasper WJ; Harris WS; Conte MS; Hills NK; Grenon SM
J Clin Lipidol; 2017; 11(5):1289-1295. PubMed ID: 28778393
[TBL] [Abstract][Full Text] [Related]
20. Pathway Markers for Pro-resolving Lipid Mediators in Maternal and Umbilical Cord Blood: A Secondary Analysis of the Mothers, Omega-3, and Mental Health Study.
Mozurkewich EL; Greenwood M; Clinton C; Berman D; Romero V; Djuric Z; Qualls C; Gronert K
Front Pharmacol; 2016; 7():274. PubMed ID: 27656142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
